The forecasted import volume of streptomycins to the US indicates a steady upward trend from 2024 to 2028, starting at 173.56 thousand kilograms in 2024 and reaching 192.28 thousand kilograms by 2028. This represents consistent year-on-year growth. Specifically, the projected growth rates from one year to the next hover around 2.77% to 2.83%. The compound annual growth rate (CAGR) over this period is approximately 2.77%, reflecting a stable increase.

Future trends to watch for include:

Potential regulatory impacts on antibiotic imports due to global health initiatives.
Development of antibiotic alternatives impacting demand.
Shifts in healthcare policies that may influence import volumes.